A Meta-Analysis of Depressive Symptom Outcomes in Randomized, Controlled Trials for PTSD. Issue 7 (July 2015)

• Record Type: Journal Article
• Authors: Ronconi, Julia McDougal; Shiner, Brian; Watts, Bradley V.
• Is Part Of: Journal of nervous and mental disease. Volume 203:Issue 7(2015:Jul.)
• Publication Date: 2015-07
• Subjects: Neurology -- Periodicals; Psychiatry -- Periodicals; Neurology; Psychiatry; Neurologie; Psychiatrie; Neurology; Psychiatry; Periodicals; 616.8005
• DOI: 10.1097/NMD.0000000000000322
• Languages: English
• ISSNs: 0022-3018

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>Posttraumatic stress disorder (PTSD) often co-occurs with depression. Current PTSD practice guidelines lack specific guidance for clinicians regarding the treatment of depressive symptoms. We conducted a meta-analysis of all randomized, placebo-controlled trials for PTSD therapies focusing on depression outcomes to inform clinicians about effective treatment options for depressive symptoms associated with PTSD. We searched literature databases for randomized, controlled clinical trials of any treatment for PTSD published between 1980 and 2013. We selected articles in which all subjects were adults with a diagnosis of PTSD based on the <italic>Diagnostic and Statistical Manual of Mental Disorders</italic> criteria, and valid PTSD and depressive symptom measures were reported. The sample consisted of 116 treatment comparisons drawn from 93 manuscripts. Evidence-based PTSD treatments are effective for comorbid depressive symptoms. Existing PTSD treatments work as well for comorbid depressive symptoms as they do for PTSD symptoms.</p> </sec> </abstract>